Effects of RANTES and MBL2 gene polymorphisms in sickle cell disease clinical outcomes: association of the g.In1.1T>C RANTES variant with protection against infections.
Omer Placide
OP
Dossou-Yovo
Isabelle
I
Zaccaria
Malika
M
Benkerrou
Michelle
M
Hauchecorne
Corinne
C
Alberti
Mohamed Chérif
MC
Rahimy
Jacques
J
Elion
Claudine
C
Lapoumeroulie
D000755:Anemia, Sickle Cell / Q000235:genetics* / Q000382:microbiology; D016470:Bacteremia / Q000150:complications / Q000235:genetics*; D018946:Chemokine CCL5 / Q000235:genetics*; D002675:Child, Preschool; D015331:Cohort Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D037601:Mannose-Binding Lectin / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis
D018946:Chemokine CCL5; C445619:MBL2 protein, human; D037601:Mannose-Binding Lectin